234 related articles for article (PubMed ID: 29224985)
1. Management and prognosis of locally recurrent rectal cancer - A national population-based study.
Westberg K; Palmer G; Hjern F; Johansson H; Holm T; Martling A
Eur J Surg Oncol; 2018 Jan; 44(1):100-107. PubMed ID: 29224985
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
3. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
Westberg K; Palmer G; Hjern F; Holm T; Martling A
Br J Surg; 2019 May; 106(6):790-798. PubMed ID: 30776087
[TBL] [Abstract][Full Text] [Related]
5. French current management and oncological results of locally recurrent rectal cancer.
Denost Q; Faucheron JL; Lefevre JH; Panis Y; Cotte E; Rouanet P; Jafari M; Capdepont M; Rullier E;
Eur J Surg Oncol; 2015 Dec; 41(12):1645-52. PubMed ID: 26482348
[TBL] [Abstract][Full Text] [Related]
6. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
Selvaggi F; Fucini C; Pellino G; Sciaudone G; Maretto I; Mondi I; Bartolini N; Caminati F; Pucciarelli S
Tech Coloproctol; 2015 Mar; 19(3):135-44. PubMed ID: 25384359
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Prognosis after Surgery for Locally Recurrent Rectal Cancer: A Retrospective Study.
Nishimuta M; Hamada K; Sumida Y; Araki M; Wakata K; Kugiyama T; Shibuya A; Hashimoto S; Ozeki K; Morino S; Kiya S; Baba M; Nakamura A
Asian Pac J Cancer Prev; 2021 May; 22(5):1531-1535. PubMed ID: 34048182
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
11. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
[TBL] [Abstract][Full Text] [Related]
12. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
13. Results of an aggressive approach to resection of locally recurrent rectal cancer.
Wells BJ; Stotland P; Ko MA; Al-Sukhni W; Wunder J; Ferguson P; Lipa J; Last L; Smith AJ; Swallow CJ
Ann Surg Oncol; 2007 Feb; 14(2):390-5. PubMed ID: 17063304
[TBL] [Abstract][Full Text] [Related]
14. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
15. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
[TBL] [Abstract][Full Text] [Related]
16. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer.
Bhangu A; Ali SM; Darzi A; Brown G; Tekkis P
Colorectal Dis; 2012 Dec; 14(12):1457-66. PubMed ID: 22356246
[TBL] [Abstract][Full Text] [Related]
18. Single-stage anterior high sacrectomy for locally recurrent rectal cancer.
Fawaz K; Smith MJ; Moises C; Smith AJ; Yee AJ
Spine (Phila Pa 1976); 2014 Mar; 39(5):443-52. PubMed ID: 24573075
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors after surgery for locally recurrent rectal cancer: an overview.
Caricato M; Borzomati D; Ausania F; Valeri S; Rosignoli A; Coppola R
Eur J Surg Oncol; 2006 Mar; 32(2):126-32. PubMed ID: 16377120
[TBL] [Abstract][Full Text] [Related]
20. Circumferential resection margin as a prognostic marker in the modern multidisciplinary management of rectal cancer.
Nikberg M; Kindler C; Chabok A; Letocha H; Shetye J; Smedh K
Dis Colon Rectum; 2015 Mar; 58(3):275-82. PubMed ID: 25664704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
